Sequencing Study Sees Frequent RAS-MAPK Mutations at Neuroblastoma Relapse
In Nature Genetics, an international team led by investigators in the US, Netherlands, and France pinpointed a role for the RAS-MAPK signaling pathway in neuroblastoma relapse.